Personalized medicine has reached a crossroads where fundamental change is not only appealing but essential, write Klarissa Hoday, Francesca Boggio, and Aleksander Ruzicic.
Klarissa Hoday et al
Advertisement
Klarissa Hoday is Principal, Francesca Boggio is Principal, and Aleksandar Ruzicic is Partner at Executive Insight.
Articles by Klarissa Hoday et al
Advertisement
Latest Updated Articles
Personalized Medicine at a CrossroadsPublished: March 27th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Bob Mauch: Strengthening the Chain
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
